GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Small and Large Bowel/Dietary nutrient patterns and the risk of IBS

Dietary nutrient patterns and the risk of IBS

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated September 1, 2025

Quick Answer

The study investigated the relationship between dietary nutrient patterns and the risk of developing Irritable Bowel Syndrome (IBS) in a diverse Iranian population. Here are the detailed findings and insights: --- ### **Study Overview** - **Objective:** To determine whether specific nutrient-based dietary patterns are linked to the likelihood of developing IBS.


The study investigated the relationship between dietary nutrient patterns and the risk of developing Irritable Bowel Syndrome (IBS) in a diverse Iranian population. Here are the detailed findings and insights:

---

### **Study Overview**

  • **Objective:** To determine whether specific nutrient-based dietary patterns are linked to the likelihood of developing IBS.
  • **Design:** A multicenter case-control study conducted in three provinces of western Iran (Khorramabad, Urmia, and Kermanshah) between 2021 and 2023.
  • **Participants:**
  • 317 IBS patients (diagnosed using Rome III criteria).
  • 601 healthy controls.
  • Total: 901 participants, with a case-to-control ratio of 1:2.
  • **Exclusion Criteria:** Chronic diseases, gastrointestinal surgery, pregnancy, smoking, alcohol use, and special diets were excluded to minimize confounding variables.

---

### **Dietary Assessment**

  • **Tool Used:** A validated 168-item Food Frequency Questionnaire (FFQ).
  • **Data Analysis:** Nutrient intake data were analyzed with Nutritionist IV software to calculate macronutrient and micronutrient levels.
  • **Nutrient Patterns Identified:** Principal Component Analysis (PCA) revealed three major nutrient patterns:

1. **Pattern I:** Rich in antioxidants (β-carotene, vitamin C, vitamin A, lutein, vitamin E, etc.).

2. **Pattern II:** Rich in maltose, fiber, glucose, and fructose.

3. **Pattern III:** High in sugars (sucrose, galactose, lactose) and caffeine.

  • Together, these patterns explained **63.59% of the variance** in dietary intake, capturing the primary dietary trends in the study population.

---

### **Key Findings**

#### **1. Pattern I: Antioxidants**

  • **Effect on IBS Risk:** Higher adherence to this pattern was associated with a **25% reduced odds of IBS** (OR = 0.75, CI 0.62–0.92).
  • **Implication:** Antioxidants, such as carotenoids and vitamins, appear to have protective effects against IBS development.
  • **Demographics:** Adherence to Pattern I was higher among educated, married, and non-smoking individuals.

#### **2. Pattern II: Fiber and Monosaccharides**

  • **Effect on IBS Risk:** This pattern showed an even stronger protective effect, with a **48% reduced odds of IBS** (OR = 0.52, CI 0.42–0.64).
  • **Implication:** Dietary fiber and fruit-based sugars (e.g., fructose, glucose) may play a significant role in protecting against IBS, despite known issues with fructose malabsorption in some IBS patients.
  • **Demographics:** Pattern II was more common among physically active individuals.

#### **3. Pattern III: Sugars and Caffeine**

  • **Effect on IBS Risk:** No significant relationship was found between this pattern and IBS risk (OR = 0.95, CI 0.80–1.12).
  • **Implication:** While sugars and caffeine are often suspected IBS triggers, this study did not find evidence supporting a direct link.
  • **Demographics:** Pattern III was more common among males and individuals with lower education levels.

---

### **Additional Insights**

  • **Symptom Severity:** None of the nutrient patterns were associated with the severity of IBS symptoms. While Patterns I and II reduced the odds of developing IBS, they did not influence how severe the disease was in those who had it.
  • **Age and Weight:**
  • No significant age differences were observed across Pattern I tertiles.
  • Patterns II and III were associated with higher age.
  • Pattern I was linked to slightly higher weight and BMI.
  • **Nutrient Sources:** In the Iranian population, fruits were the primary source of fructose and fiber in Pattern II, explaining its protective role despite potential fructose malabsorption in IBS patients.

---

### **Context with Other Studies**

  • The findings align with prior research suggesting that:
  • **Antioxidants, fiber, and phytochemicals** promote gut health and reduce IBS risk.
  • However, the study contrasts with some research that implicates **caffeine and sugars** as IBS risk factors, as no significant relationship was found for Pattern III.

---

### **Strengths of the Study**

  • **Large Sample Size:** Inclusion of 901 participants provided robust statistical power.
  • **Multicenter Design:** Enhanced diversity and generalizability of findings.
  • **Adjustment for Confounders:** Controlled for factors like age, gender, marital status, energy intake, and physical activity.
  • **Focus on Nutrient Patterns:** Analyzed dietary patterns rather than individual nutrients, offering a more realistic view of diet complexity.

---

### **Clinical Implications**

  • **Dietary Recommendations for IBS Prevention:**
  • Diets rich in **antioxidants** (e.g., vitamins A, C, E, and carotenoids) may reduce IBS risk.
  • High **fiber** and **fruit-based sugars** (e.g., from fruits) are protective and should be encouraged.
  • **Sugars and caffeine** do not appear to have a significant impact on IBS risk, but individual tolerance should still be considered.
  • These findings can inform guidelines for nutritional strategies targeting IBS prevention.

---

### **Conclusion**

The study highlights the importance of nutrient-based dietary patterns in IBS risk. Specifically, antioxidant-rich and fiber-rich diets may offer protective benefits, while high sugar and caffeine intake show no clear association. These insights could help shape future dietary recommendations for IBS prevention and management.

Related Q&A

Anal High-Grade Squamous Intraepithelial Lesions (HSIL): BJS | March 2026

Introduction: Anal squamous cell carcinoma is an increasingly common but largely preventable cancer. Most cases arise from persistent high-risk human papillomavirus (HPV) infection, progressing through high-grade squamous intraepithelial lesions (HSIL). This comprehensive review summarizes the...

Post-Infection DGBI (PI-DGBI): Gut | July 2026

Introduction: Acute infectious gastroenteritis can trigger persistent gastrointestinal symptoms long after the infection has resolved, leading to post-infection disorders of gut-brain interaction (PI-DGBI). This global Rome Foundation study evaluated the prevalence, risk factors, and clinical...

FMT in IBS: Gastroenterology | July 2026

Introduction: Gut microbiota alterations have been implicated in the pathogenesis of irritable bowel syndrome (IBS), making fecal microbiota transplantation (FMT) a promising therapeutic strategy. However, clinical trials have reported conflicting results. This updated meta-analysis evaluated...

Laparoscopic vs Open Adhesiolysis for Bowel Obstruction: JAMA Surgery | June 2026

Introduction: Laparoscopic adhesiolysis offers several short-term advantages over open surgery for adhesive small bowel obstruction (ASBO). However, its long-term impact on recurrence, quality of life, and incisional hernia remains uncertain. The LASSO trial provides the...

DPP-4 Inhibition Targets the Gut–Brain Axis in Parkinson's Disease: Gut | July 2026

Introduction: Growing evidence suggests that Parkinson's disease (PD) may originate in the gut, with pathological α-synuclein spreading to the brain through the vagus nerve. This study investigated whether sitagliptin, a widely used DPP-4 inhibitor for...

Bedside Ultrasound Outperforms Abdominal X-Ray in Neonatal Necrotizing Enterocolitis: Frontiers in Pediatrics | July 2026

Introduction: Necrotizing enterocolitis (NEC) is one of the most serious gastrointestinal emergencies in neonates. Early identification of infants requiring surgical intervention is critical but remains challenging. This study compared bedside abdominal ultrasonography (US) with abdominal...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer